Zobrazeno 1 - 6
of 6
pro vyhledávání: '"59"'
Autor:
Niu, Rui1, Liu, Ying2, Zhang, Ying1, Zhang, Yuan3, Wang, Hui1, Wang, Yongbin1, Wang, Wei1 ww8160@163.com, Li, Xiaohui4
Publikováno v:
PLoS ONE. 1/25/2017, Vol. 12 Issue 1, p1-18. 18p.
Autor:
Hagman, Helga1,2 helga.hagman@med.lu.se, Bendahl, Pär-Ola1, Lidfeldt, Jon1, Belting, Mattias1,2, Johnsson, Anders1,2
Publikováno v:
PLoS ONE. 12/28/2018, Vol. 13 Issue 12, p1-15. 15p.
Autor:
Yilmaz, Ozlem1, Patinote, Amélie1, Nguyen, Thao Vi1, Bobe, Julien1, Com, Emmanuelle2, Lavigne, Regis2, Pineau, Charles2, Sullivan, Craig V.3
Publikováno v:
PLoS ONE. 11/16/2017, Vol. 12 Issue 11, p1-24. 24p.
Autor:
Csősz, Éva1, Lábiscsák, Péter1, Kalló, Gergő1, Márkus, Bernadett1, Emri, Miklós2, Szabó, Adrienn3, Tar, Ildikó4 marton.ildiko@dental.unideb.hu, Tőzsér, József1, Kiss, Csongor5, Márton, Ildikó4
Publikováno v:
PLoS ONE. 5/18/2017, Vol. 12 Issue 5, p1-21. 21p.
Autor:
Ding, Xinghua1, Yang, Shuguang1, Li, Wuju2, Liu, Yong1, Li, Zhiguo1, Zhang, Yan3, Li, Lingjiang3, Liu, Shaojun1 liusj@bmi.ac.cn
Publikováno v:
PLoS ONE. May2014, Vol. 9 Issue 5, p1-11. 11p.
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170741 (2017)
PLoS ONE
PLoS ONE
Idiopathic pulmonary fibrosis (IPF) is a gradual lung disease with a survival of less than 5 years post-diagnosis for most patients. Poor molecular description of IPF has led to unsatisfactory interpretation of the pathogenesis of this disease, resul